Research advances of human papillomavirus-related head and neck squamous cell carcinoma

Abstract

Zeng-Wen-Fei-；Fei-Ji-Min. Research advances of human papillomavirus-related head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2015, 42(4): 288-291.

［1］ Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer［J］. N Engl J Med, 2010, 363(1): 2435. ［2］ de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis［J］. Lancet Oncol, 2012, 13(6): 607615. ［3］ Blomberg M, Nielsen A, Munk C, et al. Trends in head and neck cancer incidence in Denmark, 19782007: focus on human papillomavirus associated sites［J］. Int J Cancer, 2011, 129(3): 733741. ［4］ Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States［J］. J Clin Oncol, 2011, 29(32): 42944301. ［5］ Rettig E, Kiess AP, Fakhry C. The role of sexual behavior in head and neck cancer: implications for prevention and therapy［J］. Expert Rev Anticancer Ther, 2015, 15(1): 3549. ［6］ Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 20092010［J］. JAMA, 2012, 307(7): 693703. ［7］ Saba NF, Goodman M, Ward K, et al. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results programbased analysis［J］. Oncology, 2011, 81(1): 1220. ［8］ AlSwiahb JN, Huang CC, Fang FM, et al. Prognostic impact of pl6, p53,epidermalgrowth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nutchewing area［J］. Arch Otolaryngol Head Neck Surg, 2010, 136(5): 502508. ［9］ Nichols AC, Finkelstein DM, Faquin WC, et al. Bcl2 and human papillomavirus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer［J］. Clin Cancer Res, 2010, 16(7): 21382146. ［10］ Rietbergen MM, Snijders PJ, Beekzada D, et al. Molecular characterization of p16immunopositive but HPV DNAnegative oropharyngeal carcinomas［J］. Int J Cancer, 2014, 134(10): 23662372. ［11］ Boucek J, Mrkvan T, Chovanec M, et al. Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck［J］. J Cell Mol Med, 2010, 14(12): 426433. ［12］ Wamsom D, Light E, Thomas D, et al. Infiltrating lymphocytes and human papillomavirus16associated oropharyngeal cancer［J］. Laryngoscope, 2012, 122(1): 121127. ［13］ Lukesova E, Boucek J, Rotnaglova E, et al. High level of tregs is a positive prognostic marker in patients with HPVpositive oral and oropharyngeal squamous cell carcinomas［J］. Biomed Res Int, 2014, 2014: 303929. ［14］ Badoual C, Hans S, Merillon N, et al. PD1expressing tumorinfiltrating T cells are a favorable prognostic biomarker in HPVassociated head and neck cancer［J］. Cancer Res, 2013, 73(1): 128138. ［15］ Liang X, Zheng M, Jiang J, et al. Hypoxiainducible factor1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma［J］. Oral Oncol, 2011, 47(2): 9297. ［16］ Zhu GQ, Tang YL, Li L, et al. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma［J］. Clin Cancer Res, 2010, 16(19): 47324741. ［17］ Rahimi AS, Wilson DD, Saylor DK, et al. p16,CyclinD1,and HIF1αpredict outcomes of patients with oropharyngeal squamous cell carcinoma treated with definitive intensitymodulated radiation therapy［J］. Int J Otolaryngol, 2012, 2012: 685951. ［18］ Song X, Sturgis EM, Liu J, et al. MicroRNA variants increase the risk of HPVassociated squamous cell carcinoma of the oropharynx in never smokers［J］. PLoS One, 2013, 8(2): e56622. ［19］ Lajer CB, Nielsen FC, FriisHansen L, et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study［J］. Br J Cancer, 2011, 104(5):830840. ［20］ Hui AB, Lin A, Xu W, et al. Potentially prognostic miRNAs in HPVassociated oropharyngeal carcinoma［J］. Clin Cancer Res, 2013, 19(8): 21542162. ［21］ Guan X, Sturgis EM, Song X, et al. PremicroRNA variants predict HPV16positive tumors and survival in patients with squamous cell carcinoma of the oropharynx［J］. Cancer Lett, 2013, 330(2): 233240. ［22］ Moore EJ, Henstrom DK, Olsen KD, et al. Transoral resection of tonsillar squamous cell carcinoma［J］. Laryngoscope, 2009, 119(3): 508515. ［23］ Park YM, Lee JG, Lee WS, et al. Feasibility of transoral lateral oropharyngectomy using a robotic surgical system for tonsillar cancer［J］. Oral Oncology, 2009, 45(8): e6266. ［24］ Romanowski B. Long term protection against cervical infection with the human papillomavirus: review of currently available vaccines［J］. Hum Vaccin, 2011, 7(2): 161169. ［25］ Vermorken JB, SthlmacherWilliams J, Davidenko I, et al. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamouscell carcinoma of the head and neck (SPECTRUM): an openlabel phase 3 randomisedtrial［J］. Lancet Oncol, 2013, 14(8): 697710. ［26］ Stenner M, Yosef B, Huebbers CU, et al. Nuclear translocation of betacatenin and decreased expression of epithelial cadherin in human papillomaviruspositive tonsillar cancer: an early event in human papillomavirusrelated tumour progression?［J］. Histopathology, 2011, 58(7): 11171126.

[1]	Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor[J]. Journal of International Oncology, 2024, 51(5): 298-302.
[2]	Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552.
[3]	Chen Xinyi, Weng Yiming, Wei Jiayan, Wang Jinsong, Peng Min.Advances in immune checkpoint inhibitors in the treatment of recurrent or metastatic head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 553-557.
[4]	Ju Yifan, Xu Chenyang, Lei Dapeng.Research progress of pathomics in head and neck neoplasms[J]. Journal of International Oncology, 2023, 50(5): 294-298.
[5]	Chen Yi, Han Liang, Cai Li.Multivariate analysis of chemotherapy induced oral mucositis in patients with head and neck tumors[J]. Journal of International Oncology, 2022, 49(9): 521-525.
[6]	Zeng Yan, Luo Pan, Wang Ziqi, Wu Weili.Mechanism of drug induced ferroptosis in the treatment of head and neck tumors[J]. Journal of International Oncology, 2022, 49(3): 173-176.
[7]	Lao Zheng, Tu Wenyong, Xu Xuanli, Zhang Lin, Shao Ziyang, Shi Huifeng.Nimotuzumab combined with definitive radiotherapy for inoperable locally advanced oral and maxillofacial squamous cell carcinoma[J]. Journal of International Oncology, 2022, 49(11): 665-670.
[8]	Xu Shifei, Feng Huan, Liu Haiyang, Hu Jie, Ma Lu.Effect of rotational errors on the accuracy of positioning for head-neck tumors in radiotherapy[J]. Journal of International Oncology, 2021, 48(3): 150-155.
[9]	Qian Wenchuan, Wang Fan.A dosimetric comparison of volumetric modulated arc therapy with intensity modulated radiation therapy for head and neck cancer[J]. Journal of International Oncology, 2020, 47(8): 457-461.
[10]	Zhou Fei, Liu Rui, Lyu Hongying, Liang Donghai, Chen Wenxiu, Yu Hongsheng.Immunotherapy for head and neck cancer[J]. Journal of International Oncology, 2020, 47(12): 746-751.
[11]	Li Ang, Wei Fang.Current status and future challenges of HPV preventive vaccine of cervical cancer[J]. Journal of International Oncology, 2019, 46(5): 307-310.
[12]	Chai Yue, Dong Mei .Medical treatment in head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2019, 46(2): 94-97.
[13]	Zang Shoumei, Yan Danfang, Yan Senxiang.Advances in nonsurgical treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2019, 46(12): 741-744.
[14]	Yu Changyun, Liu Yong, Cao Hua.Effects of microRNA-205-3p and microRNA-205-5p on the cell proliferation, migration and invasion of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2018, 45(11): 641-646.
[15]	LIU Juan, MA Dai-Yuan.Research progress in radiotherapy for head and neck tumors in parotid gland protection[J]. Journal of International Oncology, 2015, 42(8): 689-.

Research advances of human papillomavirus-related head and neck squamous cell carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments